Form 4: Oncology Institute Chief Medical Officer Sells Shares to Cover Tax Obligations

Yale Podnos, Chief Medical Officer of Oncology Institute, sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• Yale Podnos, the Chief Medical Officer of Oncology Institute, sold a total of 2,992 shares of common stock on November 20, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The shares were sold at prices ranging from $0.135 to $0.168, with a volume-weighted average price of $0.136 for some transactions and $0.135 for others.
• Following these transactions, Mr. Podnos beneficially owns 72,968 shares of Oncology Institute common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares to cover tax obligations are a common practice among executives in publicly traded companies.
• The price range of $0.135 to $0.168 is specific to Oncology Institute's stock and would need to be compared to similar companies in the biotech or healthcare sector to assess if it is within a normal range for insider sales.

Stakeholder Impact

• The stock sales may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small volume of shares sold.

Key Dates

Keywords

Oncology Institute, Yale Podnos, stock sale, restricted stock units, tax obligations, insider trading, Form 4